Kai Singbartl
Overview
Explore the profile of Kai Singbartl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
2011
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Speiser L, Graf E, Seville M, Singbartl K, Dalton M, Harrington D, et al.
Emerg Infect Dis
. 2023 Apr;
29(5):1061-1063.
PMID: 37081593
We describe an incidental Burkholderia pseudomallei laboratory exposure in Arizona, USA. Because melioidosis cases are increasing in the United States and B. pseudomallei reservoirs have been discovered in the Gulf...
2.
Nanchal R, Subramanian R, Alhazzani W, Dionne J, Peppard W, Singbartl K, et al.
Crit Care Med
. 2023 Apr;
51(5):657-676.
PMID: 37052436
Objectives: To develop evidence-based recommendations for clinicians caring for adults with acute liver failure (ALF) or acute on chronic liver failure (ACLF) in the ICU. Design: The guideline panel comprised...
3.
Nanchal R, Subramanian R, Alhazzani W, Dionne J, Peppard W, Singbartl K, et al.
Crit Care Med
. 2023 Apr;
51(5):653-656.
PMID: 37052435
No abstract available.
4.
Prasad A, Brehm C, Singbartl K
Artif Organs
. 2022 Nov;
47(3):554-565.
PMID: 36325712
Background: Veno-arterial extracorporeal life support (V-A ECLS) has become a cornerstone in the management of critical cardiogenic shock, but it can also precipitate organ injury, e.g., acute kidney injury (AKI)....
5.
Smith B, Bosch W, OHoro J, Girardo M, Bolton P, Murray A, et al.
Am J Infect Control
. 2022 Sep;
51(6):607-611.
PMID: 36162605
Background: Surgical site infections (SSIs) are an undesired perioperative outcome. Recent studies have shown increases in hospital acquired infections during the coronavirus disease 2019 (COVID-19) pandemic. The objective of this...
6.
7.
Molinari L, Del Rio-Pertuz G, Smith A, Landsittel D, Singbartl K, Palevsky P, et al.
JAMA Netw Open
. 2022 May;
5(5):e2212709.
PMID: 35583867
Importance: The 23rd Acute Disease Quality Initiative (ADQI-23) consensus conference proposed a framework to integrate biomarkers into the staging of acute kidney injury (AKI). It is unknown whether tissue inhibitor...
8.
Singbartl K, Rosenthal A, Leis J, Patel B, Sen A
Crit Care Explor
. 2021 Jul;
3(7):e0472.
PMID: 34235458
Background: Chimeric antigen receptor T-cell therapies (CAR-T) are transforming the treatment of B-cell leukemias and lymphomas. Cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome represent common, potentially life-threatening toxicities...
9.
Sen A, Blakeman S, DeValeria P, Peworski D, Lanza L, Downey F, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2021 Mar;
5(2):525-531.
PMID: 33686378
Interfacility transport of a critically ill patient with acute respiratory distress syndrome (ARDS) may be necessary for a higher level of care or initiation of extracorporeal membrane oxygenation (ECMO). During...
10.
OHoro J, Cerhan J, Cahn E, Bauer P, Temesgen Z, Ebbert J, et al.
Mayo Clin Proc
. 2021 Mar;
96(3):601-618.
PMID: 33673913
Objective: To report the Mayo Clinic experience with coronavirus disease 2019 (COVID-19) related to patient outcomes. Methods: We conducted a retrospective chart review of patients with COVID-19 diagnosed between March...